UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017863
Receipt number R000020697
Scientific Title Treatment of Laryngeal Papillomatosis with Cidofovir
Date of disclosure of the study information 2015/06/11
Last modified on 2023/12/16 09:29:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Treatment of Laryngeal Papillomatosis with Cidofovir

Acronym

Treatment of Laryngeal Papillomatosis with Cidofovir

Scientific Title

Treatment of Laryngeal Papillomatosis with Cidofovir

Scientific Title:Acronym

Treatment of Laryngeal Papillomatosis with Cidofovir

Region

Japan


Condition

Condition

Laryngeal Papillomatosis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of cidofovir to laryngeal papillomatosis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

clinical findings of larynx

Key secondary outcomes

GRBAS score


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

cidofovir 7.5mg/ml local injection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pathologicaly diagnosed as larynx papilloma.
Written infomed consent to useage of cidofovir.

Key exclusion criteria

Refused to useage of cidofovir.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Mineta

Organization

HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE

Division name

Depertment of otorhinolaryngology

Zip code

431-3192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2659

Email

mineta@hama-med.ac.jp


Public contact

Name of contact person

1st name Kiyoshi
Middle name
Last name Misawa

Organization

HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE

Division name

Depertment of otorhinolaryngology

Zip code

431-3192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2659

Homepage URL


Email

kiyoshim@hama-med.ac.jp


Sponsor or person

Institute

Depertment of otorhinolaryngology, HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE

Institute

Department

Personal name



Funding Source

Organization

Depertment of otorhinolaryngology, HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

Tel

053-435-2111

Email

yamoto@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 06 Month 10 Day

Date of IRB

2015 Year 05 Month 26 Day

Anticipated trial start date

2015 Year 06 Month 11 Day

Last follow-up date

2020 Year 06 Month 10 Day

Date of closure to data entry

2020 Year 06 Month 10 Day

Date trial data considered complete

2020 Year 06 Month 10 Day

Date analysis concluded

2020 Year 06 Month 10 Day


Other

Other related information



Management information

Registered date

2015 Year 06 Month 10 Day

Last modified on

2023 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020697


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name